Asia vs South Africa: Proportion of the target population who received the final dose
Asia
14.0%
in 2024
South Africa
79.0%
in 2024
Asia rank
27th
South Africa rank
24th
Proportion of the target population who received the final dose over time
- Asia
- South Africa
How they compare
South Africa currently reports 79.0% against 14.0% in Asia, a difference of 65.0%.
That makes South Africa's figure about 5.6 times Asia's.
The two have swapped places 2 times across 11 shared years of data; in 2014 it was South Africa ahead.
Asia ranks 27th and South Africa ranks 24th of 34 groups.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Asia | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.5% | 55.0% | 53.5% | South Africa |
| 2020s | 6.0% | 47.0% | 41.0% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Asia or South Africa?
- South Africa, at 79.0% against 14.0% in Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Asia and South Africa?
- 65.0%, with South Africa ahead.
- How many years of comparable data are there for Asia and South Africa?
- 11 years are reported by both, from 2014 to 2024.
- How do Asia and South Africa rank globally for proportion of the target population who received the final dose of?
- Asia ranks 27th and South Africa ranks 24th of 34 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.